Do Not Coadminister
Quality of Evidence:
Coadministration has not been studied and is not recommended as it may significantly decrease ritonavir concentrations which may reduce the therapeutic effect. The magnitude of rifapentine-mediated CYP3A4 induction is predicted to be lower than with rifampicin but higher than with rifabutin. Consider using rifabutin.
View all available interactions with
Ritonavir (RTV) by clicking